NKCx Histopathological outcome* within 12 months after cervix cytology in 2021 |
571 Dalarna |
Benign | LSIL | HSIL | AIS | Cancer | Other | PAD missing | Total | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytologi | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel |
Benign sample | 25 | 0.5% | 53 | 1.1% | 8 | 0.2% | 3 | 0.1% | . | . | . | . | 4710 | 98.1% | 4799 | 100.0% |
ASCUS | 30 | 7.0% | 209 | 48.6% | 55 | 12.8% | 2 | 0.5% | 1 | 0.2% | 1 | 0.2% | 132 | 30.7% | 430 | 100.0% |
LSIL | 19 | 5.0% | 201 | 52.9% | 83 | 21.8% | . | . | 3 | 0.8% | 1 | 0.3% | 73 | 19.2% | 380 | 100.0% |
Atypical glandular cells/AGC | 3 | 33.3% | 3 | 33.3% | 1 | 11.1% | 2 | 22.2% | . | . | . | . | . | . | 9 | 100.0% |
Unclear atypia | . | . | 1 | 100.0% | . | . | . | . | . | . | . | . | . | . | 1 | 100.0% |
ASC-H | 2 | 3.1% | 22 | 33.8% | 39 | 60.0% | . | . | 1 | 1.5% | . | . | 1 | 1.5% | 65 | 100.0% |
HSIL | . | . | 16 | 21.9% | 54 | 74.0% | 1 | 1.4% | 2 | 2.7% | . | . | . | . | 73 | 100.0% |
Squamous cell cancer | . | . | . | . | 1 | 100.0% | . | . | . | . | . | . | . | . | 1 | 100.0% |
Totalt | 79 | 1.4% | 505 | 8.8% | 241 | 4.2% | 8 | 0.1% | 7 | 0.1% | 2 | 0.0% | 4916 | 85.4% | 5758 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80703 |